Atul appoints Rangaswamy Iyer as Independent Director
The appointment is effective from May 01, 2023 for five years
The appointment is effective from May 01, 2023 for five years
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Apollo continues to invest in genomics technology and research for better patient care
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Subscribe To Our Newsletter & Stay Updated